---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-095276"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:45:38.831586+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cyclacel receives Nasdaq delisting notice for equity deficiency; hearing set for Oct 15, 2024

## Summary
- Nasdaq Staff determined Cyclacel's stockholders' equity was below $2.5M as of June 30, 2024, violating Listing Rule 5550(b)(1).
- Company requested a hearing before Nasdaq Hearings Panel, automatically staying any suspension or delisting pending decision.
- Hearing scheduled for October 15, 2024; company will present plan to regain compliance with equity rule.
- No assurance that hearing will be successful or that company can maintain compliance if listing continues.
- If appeal denied or compliance not regained, common and preferred stock subject to delisting from Nasdaq.

## SEC filing metadata
- accession: 0001104659-24-095276
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000110465924095276/0001104659-24-095276-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000110465924095276/tm2423119d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-095276
- JSON: https://secwatch.observer/filing/0001104659-24-095276.json
- Plain text: https://secwatch.observer/filing/0001104659-24-095276.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.